Monopar Therapeutics Inc. Goodwill, Foreign Currency Translation Gain (Loss)
Monopar Therapeutics Inc. (MNPR) reported Goodwill, Foreign Currency Translation Gain (Loss) of $25.52 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2022-11-10
- Monopar Therapeutics Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-09-30 was $25.52K, a 283444.44% increase year-over-year.
- Monopar Therapeutics Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-06-30 was $21.21K.
- Monopar Therapeutics Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-09-30 was $9.00.
- Monopar Therapeutics Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2021-06-30 was -$55.00.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month |
|---|---|---|---|
| 2022-09-30 | $25.52K 10-Q · filed 2022-11-10 | $46.73K derived: sum of 2 quarters · filed 2022-11-10 | $46.15K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $21.21K 10-Q · filed 2022-08-11 | $20.63K 10-Q · filed 2022-08-11 | |
| 2021-09-30 | $9.00 10-Q · filed 2022-11-10 | -$46.00 derived: sum of 2 quarters · filed 2022-11-10 | $2.73K 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$55.00 10-Q · filed 2022-08-11 | $2.72K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |